1Dubois, MF, Hébert, R.The incidence of vascular dementia in Canada: a comparison with Europe and East Asia. Neuroepidemiology. 2001; 20(3):179–87.
2Plassman, BL, Langa, KM, Fisher, GG, et al.Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology. 2007; 29(1-2):125–32.
3Román, GC.Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci. 2002; 15(7-10):203–4.
4Fillit, H, Hill, J.The costs of vascular dementia: a comparison with Alzheimer’s disease. J Neurol Sci. 2002; 203-204:35–9.
5Serra, JA, Domínguez, RO, de Lustig, ES, et al.Parkinson’s disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson’s, Alzheimer’s and vascular dementia patients. J Neural Transm. 2001; 108(10): 1135–48.
6Drummond, GR, Selemidis, S, Griendling, KK, Sobey, CG.Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov. 2011; 10 (6):453–71.
7Polidori, MC, Mecocci, P, Frei, BF.Plasma Vitamin C levels are decreased and correlated with brain damage in patients with intracranial hemorrhage or head trauma. Stroke. 2001; 32: 898–902.
8Gustaw-Rothenberg, K, Lerner, A, Bonda, DJ, et al.Biomarkers in Alzheimer’s disease: past, present and future. Biomark Med. 2010; 4(1):15–26.
9Kadiiska, MB, Gladen, BC, Baird, DD, et al.Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med. 2005; 38(6):698–710.
10Ter Steege, JC, Koster-Kamphuis, L, van Straaten, EA, Forget, PP, Buurman, WA.Nitrotyrosine in plasma of celiac disease patients as detected by a new sandwich ELISA. Free Radic Biol Med. 1998; 25(8):953–63.
11Manolescu, BN, Berteanu, M, Oprea, E, et al. Dynamic of oxidative and nitrosative stress markers during the convalescent period of stroke patients undergoing rehabilitation. Ann Clin Biochem. 2011.
12Ryglewicz, D, Rodo, M, Kunicki, PK, et al.Plasma antioxidant activity and vascular dementia. J Neurol Sci. 2002; 203-204: 195–7.
13Rao, KS.Free radical induced oxidative damage to DNA: relation to brain aging and neurological disorders. Indian J Biochem Biophys. 2009; 46(1):9–15.
14Behl, C.Alzheimer’s disease and oxidative stress: implications for novel therapeutic approaches. Prog Neurobiol. 1999; 57(3): 301–23.
15Pilger, A, Germadnik, D, Riedel, K, Meger-Kossien, I, Scherer, G, Rüdiger, HW.Longitudinal study of urinary 8-hydroxy-2’-deoxyguanosine excretion in healthy adults. Free Radic Res. 2001; 35(3):273–80.
16Pourcelot, S, Faure, H, Firoozi, F, et al.Urinary 8-oxo-7, 8-dihydro-2’-deoxyguanosine and 5-(hydroxymethyl) uracil in smokers. Free Radic Res. 1999; 30(3):173–80.
17Musarrat, J, Arezina-Wilson, J, Wani, AA.Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis. Eur J Cancer. 1996; 32A(7):1209–14.
18Wu, LL, Chiou, CC, Chang, PY, Wu, JT.Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta. 2004; 339(1-2): 1–9.
19Praticò, D, Clark, CM, Lee, VM, Trojanowski, JQ, Rokach, J, FitzGerald, GA.Increased 8, 12-iso-iPF2alpha-VI inAlzheimer’s disease: correlation of a noninvasive index of lipid peroxidation with disease severity. Ann Neurol. 2000; 48(5):809–12.
20Praticò, D, MY Lee, V, Trojanowski, JQ, Rokach, J, Fitzgerald, GA.Increased F2-isoprostanes in Alzheimer’s disease: evidence for enhanced lipid peroxidation in vivo. FASEB J. 1998; 12(15): 1777–83.
21Kim, KM, Jung, BH, Paeng, KJ, Kim, I, Chung, BC.Increased urinary F (2)-isoprostanes levels in the patients with Alzheimer’s disease. Brain Res Bull. 2004; 64(1):47–51.
22Lee, SH, Kim, I, Chung, BC.Increased urinary level of oxidized nucleosides in patients with mild-to-moderate Alzheimer’s disease. Clin Biochem. 2007; 40(13-14):936–8.
23Cakatay, U, Telci, A, Kayalì, R, Tekeli, F, Akçay, T, Sivas, A.Relation of oxidative protein damage and nitrotyrosine levels in the aging rat brain. Exp Gerontol. 2001; 36(2):221–9.
24Doğru-Abbasoğlu, S, Parildar-Karpuzoğlu, H, Balkan, J, Aykaç-Toker, G, Uysal, M.Nitrotyrosine formation and heme oxygenase-1 expression in endotoxemic cirrhotic rats. Arch Med Res. 2007; 38(1):28–33.
25Mariani, E, Polidori, MC, Cherubini, A, Mecocci, P.Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt Technol Biomed Life Sci. 2005; 827(1):65–75.
26Yamaguchi, Y, Kagota, S, Haginaka, J, Kunitomo, M.Participation of peroxynitrite in oxidative modification of LDL by aqueous extracts of cigarette smoke. FEBS Lett. 2002; 512(1-3):218–22.
27Pignatelli, B, Li, CQ, Boffetta, P, et al.Nitrated and oxidized plasma proteins in smokers and lung cancer patients. Cancer Res. 2001; 61(2):778–84.
28Cherubini, A, Ruggiero, C, Polidori, MC, Mecocci, P.Potential markers of oxidative stress in stroke. Free Radic Biol Med. 2005; 39(7):841–52.